New Stem Cells Off Limits to Many

Rules regarding the use of cells derived from human embryos will deny many US researchers the chance to study new stem-cell lines created by cloning.

By | June 5, 2013

A colony of human ESCs (upper portion) made viause somatic-cell nuclear transfer, or cloningTACHIBANA ET AL/CELLLast month, scientists created human embryonic stem cells (hESCs) via nuclear transfer, or cloning—a breakthrough that will bring renewed interest in using embryonic stem cells to treat disease. But due to regulations of key US funding bodies, which restrict the use of human embryos in research, the work will be off limits to many labs, reported Nature.

The National Institutes of Health (NIH), which funds most of the work on stem cells in the United States, does not allow its researchers to use cells taken from embryos that were created solely for research. That rules out the stem cells produced by Shoukhrat Mitalipov of Oregon Health and Science University and colleagues, whose method involved creating an embryo by transferring the nucleus of a donor cell to an unfertilized egg cell in which the nucleus has been removed.

Researchers funded by the California Institute of Regenerative Medicine (CIRM) will also be excluded from studying the cells because Mitalipov’s team paid donors up to $7,000 for each egg they used in the experiments, and CIRM does not allow its researchers to use cell lines produced using eggs from paid donors.

George Daley of Boston Children’s Hospital in Massachusetts told Nature that the NIH’s rule is “a frustrating limitation that will preclude federal dollars being used to ask many important questions”—such as how the new cell lines compare with induced pluripotent stem cells (iPS), created by genetically reprogramming adult cells to an embryonic state. Daley added, “Most labs will take the path of least resistance and continue working with iPS cells unless someone shows that there is a clear and compelling reason to change course.”

Meanwhile, CIRM is currently reviewing its regulations regarding the research it supports, Nature reported—and it could relax its rules against using cell lines created with eggs from paid donors, according to Geoffrey Lomax, senior officer to the standards working group at CIRM.

Add a Comment

Avatar of: You



Sign In with your LabX Media Group Passport to leave a comment

Not a member? Register Now!

LabX Media Group Passport Logo


Avatar of: Paul Stein

Paul Stein

Posts: 237

June 5, 2013

Here is one reason why the massive dependence on federal funding is actually hurting some areas of science.

Avatar of: PD


Posts: 18

June 10, 2013

There are reasons why the federal gov't has regulations such as not allowing use of embryos created solely for research and not allowing the use of eggs for research from paid donors.  The reason is potential for abuse: create human clones to then kill by stealing their stem cells for the supposed good of another; abuse women by enticing them to donate their eggs with little mention of the side effects of hyper stimulation of egg production.  These regulations were created to not allow scientists to do unethical research.

One can clearly see where this research is heading all at the expense of devalued human beings.  Yes, the embryo created in IVF clinics, the cloned human from nuclear transfer and all embryos in the womb are clearly human organisms that should be treated with utmost respect, not abused by killing them after using their stem cells.  We must continue to learn from the abhorrent research conducted in Nazi concentration camp on Jews destined to be killed.  A human being deserves utmost respect at all times and at all of its stages, period.

Popular Now

  1. A Newly Identified Species Represents Its Own Eukaryotic Lineage
  2. Telomere Length and Childhood Stress Don’t Always Correlate
  3. Optogenetic Therapies Move Closer to Clinical Use
  4. Research Links Gut Health to Neurodegeneration
    The Nutshell Research Links Gut Health to Neurodegeneration

    Rodent studies presented at the Society for Neuroscience meeting this week tie pathologies in the gastrointestinal tract or microbiome composition with Parkinson’s and Alzheimer’s diseases.